Allozyne Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
Allozyne General Information
Description
Provider of protein therapeutic product candidates for the treatment of autoimmune and inflammatory diseases and cancer. The company develops technologies that improve the efficacy, safety, dosing and other characteristics of protein-based therapeutics.
Contact Information
Website
www.allozyne.comCorporate Office
- 999 Third Avenue
- Suite 3400
- Seattle, WA 98104
- United States
Corporate Office
- 999 Third Avenue
- Suite 3400
- Seattle, WA 98104
- United States
Allozyne Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 01-Jan-2014 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B2) | 15-Aug-2013 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B2) | 01-Jun-2012 | Completed | Generating Revenue | |||
| 3. Merger/Acquisition | 22-Dec-2011 | Cancelled | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 31-Oct-2007 | $33M | $36.4M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 17-Nov-2005 | $3.4M | $3.4M | Completed | Startup |
Allozyne Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A | 6,801,499 | $0.001000 | $0.06 | $1 | $1 | 1x | $1 | 14.07% |
Allozyne Comparisons
Industry
Financing
Details
Allozyne Competitors (6)
One of Allozyne’s 6 competitors is Kubota Vision, a Formerly VC-backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kubota Vision | Formerly VC-backed | Seattle, WA | ||||
| Ampio Pharmaceuticals | Corporation | Englewood, CO | ||||
| Cardiff Oncology | Formerly Angel backed | San Diego, CA | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Summit Therapeutics | Formerly VC-backed | Miami, FL |
Allozyne Patents
Allozyne Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2014140347-A2 | Novel nucleic acid molecules | Inactive | 15-Mar-2013 | ||
| WO-2014140347-A3 | Novel nucleic acid molecules | Inactive | 15-Mar-2013 | ||
| WO-2014044873-A1 | Amino acid derivatives | Inactive | 24-Sep-2012 | ||
| WO-2014044872-A1 | Cell lines | Inactive | 24-Sep-2012 | ||
| WO-2012032181-A3 | Antibody derivatives | Inactive | 10-Sep-2010 | C07K16/244 |
Allozyne Signals
Allozyne Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | ||
| Accelerator Life Science Partners | Venture Capital | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| MPM BioImpact | Venture Capital | Minority |
Allozyne FAQs
-
When was Allozyne founded?
Allozyne was founded in 2004.
-
Where is Allozyne headquartered?
Allozyne is headquartered in Seattle, WA.
-
What is the size of Allozyne?
Allozyne has 11 total employees.
-
What industry is Allozyne in?
Allozyne’s primary industry is Pharmaceuticals.
-
Is Allozyne a private or public company?
Allozyne is a Private company.
-
What is Allozyne’s current revenue?
The current revenue for Allozyne is .
-
How much funding has Allozyne raised over time?
Allozyne has raised $43.4M.
-
Who are Allozyne’s investors?
ARCH Venture Partners, Accelerator Life Science Partners, Alexandria Venture Investments, Amgen Ventures, and MPM BioImpact are 5 of 7 investors who have invested in Allozyne.
-
Who are Allozyne’s competitors?
Kubota Vision, Ampio Pharmaceuticals, Cardiff Oncology, Evonile Pharma, and Summit Therapeutics are some of the 6 competitors of Allozyne.
-
When was Allozyne acquired?
Allozyne was acquired on 01-Jan-2014.
-
Who acquired Allozyne?
Allozyne was acquired by MedImmune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process